Summary
                        
        
                            The current standard-of-care for colorectal carcinoma (CRC) is a combination of chemotherapeutics, often supplemented with targeted biological drugs. Despite recent improvements, an urgent need exists for improved efficacy, especially at late-stage disease, and minimized side...
                    
    
        
                                 
                    More information & hyperlinks
                        
        | Web resources: | https://epgl.unige.ch/mol-pharmacology/88_OPTIM_en.html | 
 
                             
                             
                            